SCHEMBL28680459

SCHEMBL28680459

CC(C)c1nccc(/C=C/C(=O)O)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ MAP3K7 O43318 1/20 0.37
▸ TAB1 Q15750 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ CA4 P22748 1/20 0.37
▸ CCNC P24863 3/20 0.36
▸ CDK8 P49336 3/20 0.36
▸ HCAR2 Q8TDS4 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ GAA P10253 3/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ P4HTM Q9NXG6 1/20 0.33
▸ PLAU P00749 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ TNKS O95271 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31053001 0.88 KDM4E (0.36) KDM4EMAPK1MAP3K7TAB1CCNC
SCHEMBL29671322 0.81 HTT (0.37) MAP3K7TAB1CCNCCDK8HTT
SCHEMBL22848034 0.81 HTT (0.37) MAP3K7TAB1CCNCCDK8HTT
SCHEMBL23693838 0.79 HRH4 (0.36) —
SCHEMBL24833024 0.77 CCR1 (0.41) ALDH1A1
SCHEMBL23685266 0.75 — —
SCHEMBL20621313 0.74 NOS3 (0.31) —
SCHEMBL19779245 0.74 NOS3 (0.31) —
SCHEMBL21173560 0.73 ALDH1A1 (0.33) KDM4EMAPK1ALDH1A1
SCHEMBL17603692 0.72 KDM4E (0.42) KDM4EMAPK1ALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114008037-B Heterocyclic compounds as KRAS G12C inhibitors 广东新契生物医药科技有限公司 2024-06-21 — — CN disclosed
CN-114008037-A Heterocyclic compounds as KRAS G12C inhibitors 广东新契生物医药科技有限公司 2022-02-01 — — CN disclosed
Send feedback